{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:53:08Z","timestamp":1773298388491,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017057","name":"Ministry of Higher Education and Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ajog.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T11:58:16Z","timestamp":1460289496000},"page":"338.e1-338.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial"],"prefix":"10.1016","volume":"215","author":[{"given":"Ahmed M.","family":"AbdElmagied","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa E.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon K.","family":"Laughlin-Tommaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina K.","family":"Hesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Woodrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa L.","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen P.","family":"Kohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Nieves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijan J.","family":"Borah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof R.","family":"Gorny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis C.","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen A.","family":"Lemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2016.04.001_bib1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Clinical practice: uterine fibroids","volume":"372","author":"Stewart","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.04.001_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/radiol.2262011716","article-title":"Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment: a prospective, randomized, and controlled clinical trial","volume":"226","author":"Pinto","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.ajog.2016.04.001_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejogrb.2005.10.008","article-title":"Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial","volume":"126","author":"Mara","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2016.04.001_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1056\/NEJMoa062003","article-title":"Committee of the Randomized Trial of Embolization versus Surgical Treatment for Fibroids. Uterine-artery embolization versus surgery for symptomatic uterine fibroids","volume":"356","author":"Edwards","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.04.001_bib5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.001_bib6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jvir.2009.07.022","article-title":"Uterine artery embolization versus laparoscopic occlusion of uterine arteries for leiomyomas: long-term results of a randomized comparative trial","volume":"20","author":"Hald","year":"2009","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ajog.2016.04.001_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","article-title":"A\u00a0randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and\u00a0gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status","volume":"93","author":"Parsanezhad","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2016.04.001_bib8","doi-asserted-by":"crossref","first-page":"105.e1","DOI":"10.1016\/j.ajog.2010.01.049","article-title":"Uterine artery embolization vs hysterectomy in\u00a0the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial","volume":"203","author":"van der Kooij","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.001_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A\u00a0randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2016.04.001_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00404-013-2775-2","article-title":"Effect of high-intensity focused ultrasound on sexual function in the treatment of uterine fibroids: comparison to conventional myomectomy","volume":"288","author":"Wang","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2016.04.001_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0197-2456(03)00023-0","article-title":"Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB): design and methods","volume":"24","author":"Dickersin","year":"2003","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ajog.2016.04.001_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cct.2003.08.008","article-title":"Medicine or surgery (Ms): a randomized clinical trial comparing hysterectomy and medical treatment in premenopausal women with abnormal uterine bleeding","volume":"25","author":"Varner","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ajog.2016.04.001_bib13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.AOG.0000292083.97478.38","article-title":"Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial","volume":"110","author":"Dickersin","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.001_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/AOG.0b013e3181f20177","article-title":"Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Lukes","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.001_bib15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.fertnstert.2011.06.062","article-title":"Comparing focused ultrasound and uterine\u00a0artery embolization for uterine fibroids: rationale and design of the Fibroid Interventions: Reducing Symptoms Today and Tomorrow (FIRSTT) trial","volume":"96","author":"Bouwsma","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2016.04.001_bib16","series-title":"Randomized controlled trials: a\u00a0user\u2019s guide","first-page":"123","author":"Jadad","year":"1998"},{"key":"10.1016\/j.ajog.2016.04.001_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bmj.330.7501.1175","article-title":"Systematic review to determine whether participation in a trial influences outcome","volume":"330","author":"Vist","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2016.04.001_bib18","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for\u00a0leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.001_bib19","first-page":"157","article-title":"User\u2019s manual for the medical outcomes study (MOS) core measures of health-related quality of life","author":"Hays","year":"1995","journal-title":"Santa Monica (CA): Rand Corp"},{"key":"10.1016\/j.ajog.2016.04.001_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a112455","article-title":"Assessing depressive symptoms in five psychiatric populations: a validation study","volume":"106","author":"Weissman","year":"1977","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2016.04.001_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J\u00a0Sex Marital Ther"},{"key":"10.1016\/j.ajog.2016.04.001_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill pain questionnaire: major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"10.1016\/j.ajog.2016.04.001_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2529712","article-title":"Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial","volume":"31","author":"Pocock","year":"1975","journal-title":"Biometrics"},{"key":"10.1016\/j.ajog.2016.04.001_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.fertnstert.2005.04.072","article-title":"Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids","volume":"85","author":"Stewart","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2016.04.001_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.AOG.0000275283.39475.f6","article-title":"Sustained relief of leiomyoma symptoms by using focused ultrasound surgery","volume":"110","author":"Stewart","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.001_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.AOG.0000296526.71749.c9","article-title":"Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID registry","volume":"111","author":"Goodwin","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.001_bib27","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.001_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0197-2456(92)90005-K","article-title":"Analysis of randomized and nonrandomized patients in clinical trials using the comprehensive cohort follow-up study design","volume":"13","author":"Olschewski","year":"1992","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ajog.2016.04.001_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/aje\/kwj079","article-title":"Combined analysis of Women\u2019s Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease","volume":"163","author":"Prentice","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2016.04.001_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/jwh.2013.4334","article-title":"The burden of uterine fibroids for African-American women: results of a national survey","volume":"22","author":"Stewart","year":"2013","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2016.04.001_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.001_bib32","first-page":"29","article-title":"Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults: United States, 2005-2012","volume":"63","author":"Agaku","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816300424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816300424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:33:11Z","timestamp":1762079591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937816300424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0002937816300424"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2016.04.001","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}